Quercetin, Kaempferol and Apigenin in Roselle (Hibiscus Sabdariffa L.)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Effect of the Flavonoids Quercetin and Genistein on The
THE EFFECT OF THE FLAVONOIDS QUERCETIN AND GENISTEIN ON THE ANTIOXIDANT ENZYMES Cu, Zn SUPEROXIDE DISMUTASE, GLUTATHIONE PEROXIDASE, AND GLUTATHIONE REDUCTASE IN MALE SPRAGUE-DAWLEY RATS by ANNETTE CAIRNS GOVERNO (Under the Direction of Joan G. Fischer) ABSTRACT Quercetin (QC) and genistein (GS) are phytochemicals found in fruits and vegetables. These compounds may exert protective effects by altering antioxidant enzyme activities. The objective of the study was to examine the effects of QC and GS supplementation on the activities of the antioxidant enzymes glutathione reductase (GR), glutathione peroxidase (GSHPx), and Cu, Zn superoxide dismutase (SOD) in liver, and SOD activity in red blood cells (RBC), as well as the Ferric Reducing Antioxidant Potential (FRAP). Male, weanling Sprague-Dawley rats (n=7-8 group) were fed quercetin at 0.3, 0.6 or 0.9g/100g of diet or genistein at 0.008, 0.012, or 0.02g/100g diet for 14d. GS supplementation significantly increased liver GSHPx activity compared to control (p<0.01). GS did not significantly alter activities of liver SOD and GR, or RBC SOD. QC did not significantly alter antioxidant enzyme activities in liver or RBC. Neither QC nor GS increased the antioxidant capacity of serum. In conclusion, low levels of GS significantly increased liver GSHPx activity, which may contribute to this isoflavone’s protective effects. INDEX WORDS: Flavonoids, Quercetin, Genistein, Copper Zinc Superoxide Dismutase, Glutathione Peroxidase, Glutathione Reductase THE EFFECT OF THE FLAVONOIDS QUERCETIN AND GENISTEIN ON THE ANTIOXIDANT ENZYMES Cu, Zn SUPEROXIDE DISMUTASE, GLUTATHIONE PEROXIDASE, AND GLUTATHIONE REDUCTASE IN MALE SPRAGUE-DAWLEY RATS by ANNETTE CAIRNS GOVERNO B., S. -
In Vivo Analysis of Bisphenol
Asian Journal of Pharmacy and Pharmacology 2019; 5(S1): 28-36 28 Research Article In vivo analysis of bisphenol A-induced sub-chronic toxicity on reproductive accessory glands of male mice and its amelioration by quercetin Sanman Samova, Hetal Doctor, Dimple Damore, Ramtej Verma Department of Zoology, BMTC and Human Genetics, School of Sciences, Gujarat University, Ahmedabad, India Received: 20 December 2018 Revised: 1 February 2019 Accepted: 25 February 2019 Abstract Objective: Bisphenol A is an endocrine disrupting chemical, widely used as a material for the production of epoxy resins and polycarbonate plastics. Food is considered as the main source of exposure to BPA as it leaches out from the food containers as well as surface coatings into it. BPA is toxic to vital organs such as liver kidney and brain. Quercetin, the most abundant flavonoid in nature, is present in large amounts in vegetables, fruits and tea. The aim of the present study was to evaluate the toxic effects of BPA in prostate gland and seminal vesicle of mice and its possible amelioration by quercetin. Material and methods: Inbred Swiss strain male albino mice were orally administered with BPA (80, 120 and 240 mg/kg body weight/day) for 45 Days. Oral administration of BPA caused significant, dose-dependent reduction in absolute and relative weights of prostate gland and seminal vesicle. Results and conclusion: Biochemical analysis revealed that protein content reduced significantly, whereas acid phosphatase activity increased significantly in prostate gland and reduction in fructose content was observed in seminal vesicle. Oral administration of quercetin (30, 60 and 90 mg/kg body weight/day) alone with high dose of BPA (240 mg/kg body weight/day) for 45 days caused significant and dose-dependent amelioration in all parameters as compared to BPA along treated group. -
Fighting Bisphenol A-Induced Male Infertility: the Power of Antioxidants
antioxidants Review Fighting Bisphenol A-Induced Male Infertility: The Power of Antioxidants Joana Santiago 1 , Joana V. Silva 1,2,3 , Manuel A. S. Santos 1 and Margarida Fardilha 1,* 1 Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (J.S.); [email protected] (J.V.S.); [email protected] (M.A.S.S.) 2 Institute for Innovation and Health Research (I3S), University of Porto, 4200-135 Porto, Portugal 3 Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-234-247-240 Abstract: Bisphenol A (BPA), a well-known endocrine disruptor present in epoxy resins and poly- carbonate plastics, negatively disturbs the male reproductive system affecting male fertility. In vivo studies showed that BPA exposure has deleterious effects on spermatogenesis by disturbing the hypothalamic–pituitary–gonadal axis and inducing oxidative stress in testis. This compound seems to disrupt hormone signalling even at low concentrations, modifying the levels of inhibin B, oestra- diol, and testosterone. The adverse effects on seminal parameters are mainly supported by studies based on urinary BPA concentration, showing a negative association between BPA levels and sperm concentration, motility, and sperm DNA damage. Recent studies explored potential approaches to treat or prevent BPA-induced testicular toxicity and male infertility. Since the effect of BPA on testicular cells and spermatozoa is associated with an increased production of reactive oxygen species, most of the pharmacological approaches are based on the use of natural or synthetic antioxidants. -
The Human Microbial Metabolism of Quercetin in Different Formulations
foods Article The human Microbial Metabolism of Quercetin in Different Formulations: An In Vitro Evaluation Giuseppe Di Pede 1 , Letizia Bresciani 2 , Luca Calani 1, Giovanna Petrangolini 3 , Antonella Riva 3 , Pietro Allegrini 3, Daniele Del Rio 2,* and Pedro Mena 1 1 Department of Food and Drugs, University of Parma, 43124 Parma, Italy; [email protected] (G.D.P.); [email protected] (L.C.); [email protected] (P.M.) 2 Department of Veterinary Science, University of Parma, 43126 Parma, Italy; [email protected] 3 Research and Development Department, Indena S.p.A., Viale Ortles, 12-20139 Milano, Italy; [email protected] (G.P.); [email protected] (A.R.); [email protected] (P.A.) * Correspondence: [email protected]; Tel.: +39-0521-033830 Received: 29 July 2020; Accepted: 10 August 2020; Published: 14 August 2020 Abstract: Quercetin is one of the main dietary flavonols, but its beneficial properties in disease prevention may be limited due to its scarce bioavailability. For this purpose, delivery systems have been designed to enhance both stability and bioavailability of bioactive compounds. This study aimed at investigating the human microbial metabolism of quercetin derived from unformulated and phytosome-formulated quercetin through an in vitro model. Both ingredients were firstly characterized for their profile in native (poly)phenols, and then fermented with human fecal microbiota for 24 h. Quantification of microbial metabolites was performed by ultra-high performance liquid chromatography coupled to mass spectrometry (uHPLC-MSn) analyses. Native quercetin, the main compound in both products, appeared less prone to microbial degradation in the phytosome-formulated version compared to the unformulated one during fecal incubation. -
(12) United States Patent (10) Patent No.: US 9,101,662 B2 Tamarkin Et Al
USOO91 01662B2 (12) United States Patent (10) Patent No.: US 9,101,662 B2 Tamarkin et al. (45) Date of Patent: *Aug. 11, 2015 (54) COMPOSITIONS WITH MODULATING A61K 47/32 (2013.01); A61 K9/0014 (2013.01); AGENTS A61 K9/0031 (2013.01); A61 K9/0034 (2013.01); A61 K9/0043 (2013.01); A61 K (71) Applicant: Foamix Pharmaceuticals Ltd., Rehovot 9/0046 (2013.01); A61 K9/0048 (2013.01); (IL) A61 K9/0056 (2013.01) (72) Inventors: Dov Tamarkin, Macabim (IL); Meir (58) Field of Classification Search Eini, Ness Ziona (IL); Doron Friedman, CPC ........................................................ A61 K9/12 Karmei Yosef (IL); Tal Berman, Rishon See application file for complete search history. le Ziyyon (IL); David Schuz, Gimzu (IL) (56) References Cited (73) Assignee: Foamix Pharmaceuticals Ltd., Rehovot U.S. PATENT DOCUMENTS (IL) 1,159,250 A 11/1915 Moulton (*) Notice: Subject to any disclaimer, the term of this 1,666,684 A 4, 1928 Carstens patent is extended or adjusted under 35 1924,972 A 8, 1933 Beckert 2,085,733. A T. 1937 Bird U.S.C. 154(b) by 0 days. 2,390,921 A 12, 1945 Clark This patent is Subject to a terminal dis 2,524,590 A 10, 1950 Boe claimer. 2,586.287 A 2/1952 Apperson 2,617,754 A 1 1/1952 Neely 2,767,712 A 10, 1956 Waterman (21) Appl. No.: 14/045,528 2.968,628 A 1/1961 Reed 3,004,894 A 10/1961 Johnson et al. (22) Filed: Oct. 3, 2013 3,062,715 A 11/1962 Reese et al. -
Pharmaceutical and Veterinary Compounds and Metabolites
PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES High quality reference materials for analytical testing of pharmaceutical and veterinary compounds and metabolites. lgcstandards.com/drehrenstorfer [email protected] LGC Quality | ISO 17034 | ISO/IEC 17025 | ISO 9001 PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES What you need to know Pharmaceutical and veterinary medicines are essential for To facilitate the fair trade of food, and to ensure a consistent human and animal welfare, but their use can leave residues and evidence-based approach to consumer protection across in both the food chain and the environment. In a 2019 survey the globe, the Codex Alimentarius Commission (“Codex”) was of EU member states, the European Food Safety Authority established in 1963. Codex is a joint agency of the FAO (Food (EFSA) found that the number one food safety concern was and Agriculture Office of the United Nations) and the WHO the misuse of antibiotics, hormones and steroids in farm (World Health Organisation). It is responsible for producing animals. This is, in part, related to the issue of growing antibiotic and maintaining the Codex Alimentarius: a compendium of resistance in humans as a result of their potential overuse in standards, guidelines and codes of practice relating to food animals. This level of concern and increasing awareness of safety. The legal framework for the authorisation, distribution the risks associated with veterinary residues entering the food and control of Veterinary Medicinal Products (VMPs) varies chain has led to many regulatory bodies increasing surveillance from country to country, but certain common principles activities for pharmaceutical and veterinary residues in food and apply which are described in the Codex guidelines. -
Performance-Based Test Guideline for Stably Transfected Transactivation in Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists
OECD/OCDE 455 Adopted: XXX OECD GUIDELINE FOR THE TESTING OF CHEMICALS Draft Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists GENERAL INTRODUCTION Performance-Based Test Guideline 1. This Performance-Based Test Guideline (PBTG) describes the methodology of Stably Transfected Transactivation In Vitro Assays to detect Estrogen Receptor Agonists and Antagonists (ER TA assays). It comprises several mechanistically and functionally similar test methods for the identification of estrogen receptor (i.e, ER, and/or ER) agonists and antagonists and should facilitate the development of new similar or modified test methods in accordance with the principles for validation set forth in the OECD Guidance Document (GD) on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment (1). The fully validated reference test methods (Annex 2 and Annex 3) that provide the basis for this PBTG are: The Stably Transfected TA (STTA) assay (2) using the (h) ERα-HeLa-9903 cell line; and The BG1Luc ER TA assay (3) using the BG1Luc-4E2 cell line which predominately expresses hERα with some contribution from hER(4) (5). Performance standards (PS) (6) (7) are available to facilitate the development and validation of similar test methods for the same hazard endpoint and allow for timely amendment of this PBTG so that new similar test methods can be added to an updated PBTG; however, similar test methods will only be added after review and agreement that performance standards are met. The test methods included in this Test Guideline can be used indiscriminately to address countries’ requirements for test results on estrogen receptor transactivation while benefiting from the Mutual Acceptance of Data. -
In Vitro Characterization of the Novel Solubilizing Excipient Soluplus
In vitro characterization of the novel solubility enhancing excipient Soluplus⃝R DISSERTATION zur Erlangung des Grades des Doktors der Naturwissenschaften der Naturwissenschaftlich-Technischen Fakultät III Chemie, Pharmazie, Bio- und Werkstoffwissenschaften der Universität des Saarlandes von Michael Linn Saarbrücken 2011 Tag des Kolloquiums: 19. Dezember 2011 Dekan: Prof. Dr. Wilhelm F. Maier Berichterstatter: Prof. Dr. Claus-Michael Lehr Prof. Dr. Rolf Hartmann Vorsitz: Prof. Dr. Ingolf Bernhardt Akad. Mitarbeiter: Dr. Matthias Engel To my offspring The important thing is not to stop questioning. Curiosity has its own reason for existing. Albert Einstein Table of Contents Table of Contents 1. Short summary V 2. Kurzzusammenfassung VII 3. General Introduction 1 3.1. Liberation and absorption of drugs after oral application ........... 1 3.1.1. Drug solubility and dissolution ...................... 2 3.1.2. Principles of drug absorption across the intestinal mucosa ..... 4 3.2. Formulation of poorly aqueous soluble drugs by micellar solubilization .. 10 3.3. Solid dispersions and hot melt extrusion ..................... 14 3.3.1. Solid dispersions for pharmaceutical applications ........... 14 3.3.2. Hot melt extrusion ............................. 15 3.4. The novel solubility enhancer Soluplus⃝R ..................... 18 3.5. The Caco-2 cell culture model ........................... 19 3.6. Aims of this thesis .................................. 21 3.6.1. The Caco-2 model as predictive tool for Soluplus⃝R formulations .. 22 3.6.2. Potential inhibition of P-glycoprotein and/or trypsin by Soluplus⃝R . 23 3.6.3. Optimization of Soluplus⃝R formulations ................ 23 4. Soluplus⃝R as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo 25 4.1. -
During This Time of Great Societal Stress, We Are Here to Contribute Our Knowledge and Experience to Your Health and Wellbeing
During this time of great societal stress, we are here to contribute our knowledge and experience to your health and wellbeing. There is a high level of interest in evidence-based integrative strategies to augment public health measures to prevent COVID-19 virus infection and associated pneumonia. Unfortunately, no integrative measures have been validated in human trials specifically for COVID-19. Notwithstanding, this is an opportune time to be proactive. Using available evidence, we offer the following strategies for you to consider to enhance your immune system to reduce the severity or the duration of a viral infection. Again, we stress that these are supplemental considerations to the current recommendations that emphasize regular hand washing, physical distancing, stopping non-essential travel, and getting tested if you develop symptoms. RISK REDUCTION: • Adequate sleep: Shorter sleep duration increases the risk of infectious illness. Adequate sleep also ensures the secretion of melatonin, a molecule which may play a role in reducing coronavirus virulence (see Melatonin below). • Stress management: Psychological stress disrupts immune regulation. Various mindfulness techniques such as meditation, breathing exercises, and guided imagery reduce stress. • Zinc: Coronaviruses appear to be susceptible to the viral inhibitory actions of zinc. Zinc may prevent coronavirus entry into cells and appears to reduce coronavirus virulence. Typical daily dosing of zinc is 15mg – 30mg daily with lozenges potentially providing direct protective effects in the upper respiratory tract. • Vegetables and Fruits: Vegetables and fruits provide a repository of flavonoids that are considered a cornerstone of an anti-inflammatory diet. At least 5–7 servings of vegetables and 2–3 servings of fruits are recommended daily. -
(12) Patent Application Publication (10) Pub. No.: US 2014/0302163 A1 Sanchez Et Al
US 20140302163A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0302163 A1 Sanchez et al. (43) Pub. Date: Oct. 9, 2014 (54) WATER WITH IMPROVED TRANSDERMAL A613 L/714 (2006.01) AND CELLULAR DELIVERY PROPERTIES A 6LX3/59 (2006.01) AND METHODS OF MANUFACTURE AND A 6LX3/593 (2006.01) USE THEREOF A2.3L 2/52 (2006.01) A63/94 (2006.01) (71) Applicant: Subtech Industries, LLC, Stuart, FL (52) U.S. Cl. (US) CPC. A23L I/293 (2013.01); A23L 2/52 (2013.01); C02F I/30 (2013.01); A61 K33/00 (2013.01); (72) Inventors: David Sanchez, Port Saint Lucie, FL A6 IK3I/194 (2013.01); A61 K3I/714 (US); Len Deweerdt, Port Saint Lucie, (2013.01); A61 K3I/519 (2013.01); A61 K FL (US) 31/593 (2013.01); A61K 36/02 (2013.01) USPC ................. 424/600; 426/2: 426/66; 210/251: (73) Assignee: Subtech Industries, LLC, Stuart, FL 210/198.1; 210/201; 210/202: 514/569; 514/52: (US) 424/195.17; 514/789 (21) Appl. No.: 14/214,945 (57) ABSTRACT 1-1. A process for preparing conventional water sources for pro (22) Filed: Mar 16, 2014 viding “ideal state' cellular wellness benefits via topical Related U.S. Application Data hydrationabsorption. and The natural invention’s transdermal, process considersepithelial preconditioned O epicellular (60) Provisional application No. 61/788,206, filed on Mar. water sources that have removed solids, dissolved solids, 15, 2013. contaminants—both organic and inorganic and Subsequently the method purifies the water respective of removing patho Publication Classification gens, and structures the water for cellular uptake in the form of vicinal grade water, with improved characteristics of ideal (51) Int. -
Biofactors in Food Promote Health by Enhancing Mitochondrial Function
ReVieW aRticle ▼ Biofactors in food promote health by enhancing mitochondrial function by Sonia F. Shenoy, Winyoo Chowanadisai, Edward Sharman, Carl L. Keen, Jiankang Liu and Robert B. Rucker Mitochondrial function has been linked to protection from and symptom reduc- UC Davis M. Steinberg, Francine tion in chronic diseases such as heart dis- ease, diabetes and metabolic syndrome. We review a number of phytochemicals and biofactors that influence mitochon- drial function and oxidative metabolism. These include resveratrol found in grapes; several plant-derived flavonoids (quercetin, epicatechin, catechin and procyanidins); and two tyrosine-derived quinones, hydroxytyrosol in olive oil and pyrroloquinoline quinone, a minor but ubiquitous component of plant and animal tissues. In plants, these biofac- tors serve as pigments, phytoalexins or growth factors. In animals, positive nutritional and physiological attributes Biofactors in food play a role in enhancing mitochondrial function, thereby decreasing the risk of some chronic diseases. Top, a mouse that has been deprived of pyrroloquinoline quinone (PQQ), have been established for each, particu- a ubiquitous bacterial compound found in fermented products, tea, cocoa and legumes. Above, a larly with respect to their ability to affect mouse fed a diet containing PQQ. energy metabolism, cell signaling and mitochondrial function. that our body does not normally produce) attributes has been described and vali- that must be either eliminated or put to dated for each of these compounds. novel uses in the body. Many xenobiotics Biological properties of resveratrol ne of the most promising current ar- in foods can influence specific metabolic Oeas of nutritional research focuses on functions, acting as bioactive factors (bio- Resveratrol is a stilbenoid (a type of plant compounds with positive health ef- factors). -
Relationships Between the Content of Phenolic Compounds and the Antioxidant Activity of Polish Honey Varieties As a Tool for Botanical Discrimination
molecules Article Relationships between the Content of Phenolic Compounds and the Antioxidant Activity of Polish Honey Varieties as a Tool for Botanical Discrimination Monika K˛edzierska-Matysek 1, Małgorzata Stryjecka 2, Anna Teter 1 , Piotr Skałecki 1, Piotr Domaradzki 1 and Mariusz Florek 1,* 1 Institute of Quality Assessment and Processing of Animal Products, University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland; [email protected] (M.K.-M.); [email protected] (A.T.); [email protected] (P.S.); [email protected] (P.D.) 2 Institute of Agricultural Sciences, State School of Higher Education in Chełm, Pocztowa 54, 22-100 Chełm, Poland; [email protected] * Correspondence: mariusz.fl[email protected]; Tel.: +48-81-4456621 Abstract: The study compared the content of eight phenolic acids and four flavonoids and the antioxidant activity of six Polish varietal honeys. An attempt was also made to determine the correlations between the antioxidant parameters of the honeys and their polyphenol profile using principal component analysis. Total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity (ABTS) and reduction capacity (FRAP) were determined spectrophotometrically, and the phenolic compounds were determined using high-performance liquid chromatography (HPLC). The buckwheat honeys showed the strongest antioxidant activity, most likely because they had the highest Citation: K˛edzierska-Matysek,M.; concentrations of total phenols, total flavonoids, p-hydroxybenzoic acid, caffeic acid, p-coumaric acid, Stryjecka, M.; Teter, A.; Skałecki, P.; vanillic acid and chrysin. The principal component analysis (PCA) of the data showed significant Domaradzki, P.; Florek, M.